Filter by:
Scott Anders, MD, CMO, Value-Based Care, Providence Clinical Network
Dr. Anders is a physician executive with over 20 years of leadership experience in large, complex healthcare organizations with a passion for Value-Based Care, strategy development, operational execution, system excellence, process improvement, patient and employee engagement, technology integration and physician leadership growth. He currently leads Value-Based programs for Providence. In his prior role he served as the national Chief Medical Officer for all employed physician at Tenet Healthcare Corporation based out of Dallas. Dr. Anders maintains board certification in Family Medicine. He has an executive MBA from the University of Utah David Eccles School of Business and received certification as a physician executive from the American College of Physician Executives. He graduated Summa Cum Laude in Aerospace Engineering and Mechanics before enrolling in medical school.
Julie Barnes, Founder & Principal, Maverick Health Policy
Julie Barnes is the Founder and CEO of Maverick Health Policy, a consulting firm located in the Washington, DC area. Maverick provides strategic advice to organizations that need guidance about federal health information policy. As a former policy analyst, health care litigator, and Capitol Hill staffer, Ms. Barnes informs business strategy and investment decisions about digital health and payment policy. She and her team offer expert analysis about interoperability, price transparency, data privacy, artificial intelligence, value-based care, and related issues to traditional health care entities, technology companies, and venture capital firms. Prior to founding Maverick Health Policy, Ms. Barnes served as Vice President of Federal Strategy at Cambia Health Solutions, a Senior Advisor for Leavitt Partners, Director of Health Policy at two think tanks-the Bipartisan Policy Center and New America Foundation-and was an attorney at Crowell & Moring. While she was an attorney, Ms. Barnes was the long-time chairperson of the American Health Lawyers Association Health Reform Educational Task Force and Editor-in-Chief of a legal textbook on managed care.
Rajaie Batniji, MD, PhD, Co-Founder & CEO, Waymark
Rajaie Batniji, MD, PhD, is a physician and entrepreneur passionate about improving care delivery. As co-founder and CEO at Waymark, he leads a team that is catalyzing improvement in access and outcomes for people with Medicaid benefits through technology-enabled community care. Waymark partners with leading Medicaid health plans, major health systems, and federally qualified health centers to extend care beyond the clinic with a new local care delivery workforce powered by technology to deliver interventions proven to improve outcomes in a value-enabled care model. Prior to Waymark, Dr. Batniji was co-founder of Collective Health, where he was chief health officer for eight years, growing the company to serve hundreds of thousands of members. Batniji was previously a clinical assistant professor of medicine at Stanford University, where he trained in internal medicine. He holds BA and MA degrees from Stanford University, an MD from the University of California, San Francisco, and a doctorate in politics and international relations from Oxford University, where he studied as a Marshall Scholar. Batniji’s research has been published in top international medical journals, including The Lancet, Health Affairs, British Medical Journal, and the Bulletin of the World Health Organization. His work has been featured in major media, including the New York Times, Wall Street Journal, Bloomberg, Forbes, STAT, among others. Batniji lives in San Francisco with his wife and young children.
Sanjiv Baxi, MD, PhD, MPH, FIDSA, Partner, McKinsey & Company
Sanjiv is a Partner in McKinsey’s San Francisco office where he focuses on public health and healthcare finance, strategy, and operations, serving healthcare providers as well as technology and services companies. Sanjiv is passionate about bringing advanced analytics into the healthcare fold in order to improve financial performance, reduce friction, improve care delivery, and accelerate institutional digital transformation.
Milo Bissin, Southwest & Central US Market Manager, Life Sciences and Healthcare, Silicon Valley Bank
Milo Bissin is Director of the Medical Device and Healthtech portfolio in the Southwest and Central region for Silicon Valley Bank’s Life Science and Healthcare group. Based in San Diego, he is responsible for providing his clients with valuable advice and insights about their relevant sector and delivering customized financial solutions leveraging SVB’s unique platform. In his 15 years with SVB, Milo has worked with private and public companies of all life stages across the technology and life science sectors and originated several hundred million dollars in new loans to support his clients and increase their probability of success. Milo holds a bachelor’s degree in Finance from Santa Clara University.
Christine Brocato, System Vice President, Strategic Innovation, CommonSpirit Health
Christine Brocato is the System VP of Strategic Innovation at CommonSpirit Health, the parent company of Dignity Health and Catholic Health Initiatives. In close partnership with operational leaders , Christine co-leads innovation projects related to care automation, behavioral health, transportation, population health, and ambulatory care transformation. Christine is passionate about helping vulnerable and Medicaid populations receive access to patient- centered care and access to social resources that prevent health disparities. She has more than 15 years of healthcare management experience, with leadership roles that shaped business strategy, corporate development initiatives and product roadmaps at Genentech, Abbott Vascular, and Kaiser Permanente. Christine has an MBA from Georgetown University and Bachelors of Science in Combined Sciences from Santa Clara University. Christine lives in the Bay Area with her husband and two daughters. In her free time, she advocates for closing the digital divide for Oakland’s youth as an active Board Member of TechExchange.
Stephen Buck, Co-Founder and Chief Product Officer, Trial Library
Stephen Buck is the Co-founder and Chief Product Officer of Trial Library. He previously founded RxDividends which was sold to GoodRx where he joined the founding team. He also co-founded CancerSurvivalRates.com a website that has helped over 500,000 patients and physicians with prognostic information. Stephen previously served as Vice President at McKesson and led digital health product development at IQVIA.
Justin W Butler, Partner, Eclipse
Justin is a Partner at Eclipse, where he collaborates with founders working at the intersection of multiple disciplines. He is particularly passionate about novel approaches to complex issues in infrastructure in healthcare and life sciences. Justin works with companies building technologies, products, and services that enable the development and, ultimately, the foundation upon which the next generation of healthcare and life sciences advancements can thrive. His focus is on building the infrastructure of these industries, closing the gap between scientific development and clinical deployment. Prior to joining Eclipse, Justin built and led the commercial operations at Misfit, a digital health company acquired by the Fossil Group for more than $250M. Before Misfit, Justin managed the commercialization efforts in the foods, fuels, and chemicals spaces at Synthetic Genomics (SGI), a leading synthetic biology company. Justin received his B.S. in Chemical Engineering from UCSB and his MBA from MIT Sloan. He sits on the Industry Alliance Board of the California Institute for Regenerative Medicine (CIRM) and the Commercial Advisory Board of the National Science Foundation Center for Cell Manufacturing Technology (CMat). Justin enjoys skiing, mountain biking, and sailing and leads the Kathryn Butler Foundation in honor of his late wife, where he is working to support the needs of those battling cancer and bereaved children.
Connie Chen, MD, COO, Lyra Health
Dr. Connie Chen is the chief operating officer and chief medical officer at Lyra Health, where she is responsible for our operational, clinical and product teams. She was the co-founder and former chief medical officer at Vida Health. Dr. Chen currently serves on the Board of Overseers at the University of California, San Francisco. She has published extensively on open frameworks for mobile health as well as use of comparative effectiveness research design in leading medical journals such as the Journal of the American Medical Association, Archives of Internal Medicine, and the Journal of Medical Internet Research. She earned a bachelor’s degree in economics at Harvard and a medical doctorate from UCSF, and completed her internal medicine training at Stanford.
Ashok Chennuru, Global Chief Data & Insights Officer, Elevance Health
As the Global Chief Data & Insights Officer, Ashok oversees the responsibility of carrying out the vision of Carelon Digital Platforms and bringing to life digital solutions that enhance healthcare outcomes and accelerates the company growth by reimagining care delivery, operations, and customer experiences. He is particularly passionate about using data analytics to drive a digital-first approach across the company's artificial intelligence (AI), exponential technology, service experience, and innovation portfolios as well as the commercialization efforts of the organization's digital capabilities for consumers, care providers, and the health ecosystem.
Julia Colpitts, Vice President, Product Management, EBSCO Clinical Decisions
Julia Colpitts is the Vice President of Product Management for EBSCO Clinical Decisions’ DynaMed product family. She has held a variety of roles on the DynaMed team including editorial, project, and operations management leading her to her current role as the VP. She is responsible for leading the planning and development of enhancements to EBSCO Clinical Decisions products designed for physicians, advanced practice providers, and pharmacists.
Edward Cox, Head & General Manager, Digital Health & Medicines (DHM), Pfizer, Inc.
Edward Cox is an innovative, inspiring, and relentless life science and digital health executive. With a background in executive leadership, pharma, tech, investment banking and public markets, he is uniquely positioned to lead digital health through fundraising, strategic partnering, FDA approval and exit.
Christiana DelloRusso, PhD, Partner, LRVHealth
Christiana DelloRusso is a Partner at LRVHealth, having joined the firm as a Venture Partner in 2021. Her experience as an “insider” strategic healthcare investor includes her role as one of three initial partners that in 2014 launched Providence Ventures-the strategic venture capital arm of the Providence health system. There, Christiana led the firm’s investments in Omada Health, Lyra Health, and N-of-One (acquired by Qiagen). Prior to Providence, she was Vice President of Commercialization at state trade association Life Science Washington; and Managing Director of WINGS, a medical technology angel investor network. Prior roles include consulting at venture-funded startup companies, Program Manager of the Boston-based nonprofit Women Entrepreneurs in Science and Technology, and owner/operator of a women’s health business. Christiana received her PhD in Physiology from the University of Michigan and completed post-doctoral studies at the University of Washington and Children’s Hospital Boston/Harvard Medical School.
Matt Emery, General Partner, JMI Equity
Matt leads JMI Equity's healthcare technology investment team. He currently oversees the investments or serves on the boards of CipherHealth, Clio, Jane Software, PointClickCare, TimelyCare, and has previously led investments in Capsule Tech, Healthx, and Navicure (Waystar).
Daniel G. Gebremedhin, MD, Partner, Flare Capital Partners
Dan Gebremedhin, MD, is a Partner at Flare Capital Partners and serves on the Board of Flare portfolio companies Somatus, Eden Health, Positive Development, Vita Health, Oui Therapeutics, and Elektra Health. Prior to joining Flare Capital, Dan served as a Medical Director at the Harvard Pilgrim Health Plan. Dan spent over 8 years as a practicing Internal Medicine Physician on the Faculty of the Massachusetts General Hospital and Instructor in Medicine at Harvard Medical School, after completing Internal Medicine Residency at the Massachusetts General Hospital in 2010. Dan served on Former Massachusetts Governor Charlie Baker’s Board of Nursing Home Administrators from 2016 to 2020. He has served as a Senior Health Policy Advisor for the Campaigns of Former Governor Charlie Baker, Former Congressman Joseph Kennedy III, and Congressman Jake Auchincloss. Dan earned a BS from the University of California, San Diego, an MD from the Morehouse School of Medicine, and an MBA from the Harvard Business School.
Anna Haghgooie, Managing Director, Valtruis; Operating Partner, Welsh, Carson, Anderson & Stowe (WCAS)
Anna Haghgooie is a Managing Director at Valtruis, a Welsh, Carson, Anderson & Stow (WCAS) company and an Operating Partner at WCAS. Valtruis, is a unique platform that invests in and partners with disruptive leaders whose mission is to align and transform healthcare through value-based care. Valtruis is investing +$600M into companies and building portfolio support capabilities to help our companies take on and manage risk at scale. Previously, Anna was a Managing Director of the Blue Venture Fund and Sandbox Industries. The Blue Venture Fund is a unique collaboration between BCBS companies, BCBSA, and Sandbox, where she managed over $900M in capital across four funds. Anna currently serves on the boards of Wayspring, InStride Health, Oncology Care Partners, TailorCare, and Tuesday Health. She previously served on the boards of Contessa, PWN Health, ExactCare, naviHealth, Change Healthcare, Quilted Health, Somatus, ZeOmega, and SonarMD. Anna earned a bachelor’s degree from the University of Michigan and a MBA with honors from the University of Chicago Booth School of Business. Anna is a Fellow in the Health Innovators Fellowship at the Aspen Institute and lives in Chicago, IL with her husband and two children.
Jonathan Hirsch, Chief Strategy and Growth Officer, Paradigm
Jonathan Hirsch is a member of the founding team and the Chief Strategy and Growth Officer of Paradigm. Jonathan is a company founder, investor, and advisor at the intersection of healthcare, life sciences, and data. Previously, Jonathan founded Syapse in 2008, and subsequently defined and implemented a vision for transforming cancer care through precision medicine and real world evidence. Jonathan serves on the Advisory Boards of companies including Freenome and VizAI, and has helped shape the regulatory use of real world evidence through creating and serving as Principal Investigator for a Research Collaboration with the FDA. Jonathan has catalyzed national cancer data-sharing networks, including serving on the White House Cancer Moonshot Data Sharing Working Group. As an active investor and partner in venture funds, including the Kleiner Perkins seed fund and Rebel Fund, Jonathan has incubated and invested in dozens of companies at the intersection of healthcare and technology.
Jenny Ismert, Senior Vice President of Strategy Operations, UnitedHealthcare Community & State
Jenny Ismert is the Senior Vice President of Strategy in the Medicaid business for UnitedHealthcare. UnitedHealthcare Community & State proudly serves nearly six million Medicaid members, including more than 2.7 million children, in 31 states, plus Washington D.C. UnitedHealthcare is a division of UnitedHealth Group (NYSE: UNH) which is a diversified health and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. UnitedHealthcare Community & State leverages the national capabilities of UnitedHealth Group and delivers them at the local market level to support effective care management, strong regulatory partnerships, greater administrative efficiency, improved clinical outcomes, and the ability to adapt to a changing market environment. As Senior Vice President of Strategy, Jenny leads innovation, mergers and acquisitions, and working across the UnitedHealth Group enterprise on digital and technology advancements to help make the health care system work better for everyone. Prior to serving as Senior Vice President of Strategy, Jenny held a number of leadership positions with UnitedHealthcare Community & State, including Vice President of Innovation, Vice President of Policy and Strategic Engagement and Vice President of Housing. Combined, Jenny has more than 20 years of experience in the health care industry with the vast majority of her career focused on Medicaid. Jenny earned her Bachelor’s of Science degree in Biology at the University of North Texas, and a Master’s of Business Administration, with a major in Health Administration, from the University of Colorado at Denver, Colorado. For more information about UnitedHealthcare, visit www.uhc.com, or follow @myUHC on Twitter and join the conversation on our UnitedHealthcare Community Plan Facebook page.
Nandini Kashyap, Senior Director, Conferences and Social Media Strategy, Cambridge Healthtech Institute
Nandini is a seasoned professional who seamlessly transitioned from a successful career as a pharmaceutical scientist to becoming a conference and business networking expert, amassing over 16 years of invaluable experience within the biopharmaceutical industry and the partnering ecosystem. As the Senior Director of Conferences and Social Media Strategy at Cambridge Healthtech Institute, she and her team play a pivotal role in fostering connections among key stakeholders in the biotech, MedTech, and digital health sectors. She holds a bachelor's in Pharmacy and a master's in Pharmacy in Pharmaceutics and is a published author and speaker in diabetes and insulin delivery space. Beyond her professional endeavors, she is a fitness enthusiast who passionately advocates fitness and postpartum weight loss. She is an Indian American Pageant winner and enjoys dancing, modeling, and being the human spinner in response to endless requests of "Mommy, spin me!".
Missy Krasner, Venture Chair, Redesign Health
Missy is a seasoned healthcare operator with 35+ years in the healthcare and digital health industry. She has worked at large technology companies (Amazon, Google, Box), startups, foundations, the U.S. government, and venture capital. She is currently a Venture Chair at Redesign Health, a mission-driven innovation platform that launches transformative healthcare companies. Prior to Redesign, she worked at Amazon spearheading the Alexa Health & Wellness team. Prior to Amazon, Missy served as Vice President and Managing Director of Healthcare & Life Sciences at Box, a publicly traded cloud collaboration company. In that role, she led the company’s first healthcare corporate acquisition and launched the industries division in preparation for the company's IPO. Before Box, Missy was Vice President at Morgenthaler Ventures (now Canvas Ventures), a venture capital firm with $3B under management. At Morgenthaler, she helped lead Series A and B digital health investments, including: Practice Fusion, Doximity, HealthLoop, Viewics and Vida Health. Before venture capital, Missy served as one of the founding executives of Google Health, where she spearheaded Google’s first entry into the healthcare industry. While at Google, she held various positions in product management, marketing and business development. Prior to Google, Missy worked for the government in the U.S. Department of Health and Human Services (HHS) under President George W. Bush. In D.C., Missy helped start the inaugural Office of the National Coordinator for Health Information Technology (ONC) where she worked on legislation that led to the HITECH Act. Earlier in her career, she worked in Product Marketing at CareScience, a digital health startup that went public and developed the first Health Information Exchange (HIE), led policy and communications at the Kaiser Family Foundation, a healthcare policy think tank, and worked at Aetna in provider marketing during two corporate mergers. Missy has served as a board member to several digital health companies, her active boards include: Wavely (a smart phone-based pediatric diagnostic which virtually diagnoses ear infections), Uplift (a behavioral health company), Motto (a virtual specialty company), Syntax (a Value-based Care workflow company). Missy has a M.A. from Stanford University and a B.A. from UCLA.
Benjamin Lakin, PhD, President, Cambridge Innovation Institute
Ben leads the innovation and technology team at Cambridge Innovation Institute (CII) to usher in new products, strategies, software, and work-flow improvements. He has been with CII since 2018. Prior to joining CII, Ben worked as a Scientist at Smith & Nephew, where he helped launch several bioresorbable implants to repair knee, hip and shoulder pathologies, and he also led the development and characterization of new polymers/biocomposites and wearables for enhanced healing. Ben received his BS in Mechanical Engineering from the University of Maine, worked as a Process Engineer for Procter & Gamble, and then earned his MS and PhD in Biomedical Engineering from Boston University. He has authored over 10 peer-reviewed publications and delivered over 20 conference presentations.
Tom X. Lee, MD, CEO, Galileo
Tom is the CEO and visionary behind Galileo -- a next-generation health care delivery model designed for the future. Using innovative technology and human-centered design, Galileo improves clinical outcomes while reducing total cost of care across broad, complex and diverse populations.Prior to Galileo, Tom helped build One Medical into the leading, independent primary care system in the country. In addition, he was responsible for mobile and web products at Epocrates, serving as Chief Medical Officer and lead designer.Tom is a board-certified internist who completed training at Harvard’s Brigham and Women’s Hospital. He received his BS from Yale University, MD from the University of Washington School of Medicine, and MBA from Stanford University’s Graduate School of Business.
Aabed Meer, MD, Partner, Questa Capital
Aabed Meer, MD is a Partner at Questa Capital focused on growth-stage healthcare technology, healthcare services, and medical device investments. His investments include, Epic Systems, Altruista Health (acquired by Blackstone), HealthPlan Services (acquired by Wipro), Performance Health (acquired by Patterson Medical), AAI Pharma (acquired by CML/Alcami), and Breg. Previously, he was a Director and member of the founding team at Martis Capital, where he focused on private equity investments in the healthcare sector. Prior to that, he was with Capricorn Investment Group and New Enterprise Associates. Early in his career, he contributed to the Human Genome Project, an international research effort led by the National Institutes of Health. He also worked on health economics and policy matters at Kaiser Permanente and the U.K.’s National Health Service. He graduated from Harvard University with an AB in Biochemical Sciences, and from Stanford University with an MD and MBA. He completed his medical residency training at Stanford University and continues to serve as a Clinical Assistant Professor.
Tarun Mehra, Vice President, Healthcare Strategy, M&A and Partnerships, Microsoft (Nuance)
Tarun Mehra is Vice President of Healthcare Strategy, M&A, and Partnerships at Microsoft / Nuance. His role is focused on advancing the overarching Nuance + Microsoft Healthcare strategy across Provider and Payor segments. Prior to his current role, Tarun spent about 18 years in various strategy consulting roles serving large corporate and private equity clients in healthcare and technology sectors. Most recently, Tarun was an Associate Partner with Monitor Group (now Deloitte) advising large IDNs and health plans on growth strategy, portfolio assessment, M&A due diligence, and innovation strategy. Prior to that, he led the healthcare consulting business at Fuld & Co. and also founded a new line of business for the firm, which he ran as CEO for two years before helping find a strategic exit. He began his career in technology and product development and later transitioned to business strategy roles post his MBA. Tarun completed mechanical engineering from Indian Institute of Technology (IIT), Delhi, and received his MBA from Indian Institute of Management (IIM), Indore.
Fatima Paruk, MD, Senior Vice President & Chief Health Officer, Health & Life Sciences, Salesforce, Inc.
Dr. Paruk has recently joined Salesforce as Chief Health Officer & Senior Vice President Industry Advisory for HLS. She brings her experience as a practicing physician, CMO, and clinical technology strategy consultant to Salesforce’s HLS. Prior to her joining Salesforce, Fatima came from McKinsey Co., where she led McKinsey’s Clinical Center of Excellence. She has also served as Chief Medical Information Officer for Microsoft US Health & Life Sciences, and CMO of Analytics and Consumer Wellness at Allscripts, where she provided medical leadership to a world-class team of data scientists. Dr. Paruk successfully demonstrated the power of big data in improving health outcomes. Her team facilitated early identification of chronic diseases, successfully quantified impacts of social determinants of health, and worked to deliver such insights to the point-of-care, to clinicians within their workflows, and to consumers.
Dipa D Patolia, Senior Director of Population Health & Clinical Operations, Health Net
Dipa Patolia serves as the Senior Director of Population Health and Clinical Operations at Health Net, a subsidiary of Centene, as well as the Executive Sponsor of CA cPRIDE, Centene's LGBTQIA focused Employee Inclusion Group. In her role, Dipa is responsible for designing and implementing innovative and meaningful programs to meet the social, behavioral, and physical needs of Health Net’s members as well as to lead the clinical & non-clinical, telephonic & field-based population health outreach teams to improve member engagement and outcomes. Dipa, a clinical pharmacist by training, has several years of experience in the managed care, FQHC, and inpatient settings, including at safety net hospitals in Central CA, Los Angeles, and NYC. She has a special interest in Substance Use Disorder, Oncology, and Specialty Condition Management, and equitable program development focused on minority and LGBTQ+ Health.
Irem Rami, Principal, Healthcare, Norwest Venture Partners
Irem brings over a decade of investing and operating experience across various stages of healthcare services and healthcare technology companies. At Norwest, she focuses on venture and growth equity opportunities across healthcare services, healthcare IT, pharma services, and digital health. Prior to Norwest, she worked at Summit Partners and McKesson Ventures. She also served in product and business development roles with healthcare startups Omada Health and Caremerge (acquired by VoiceFriend). Irem holds a BS in biomedical engineering and economics, magna cum laude, from Duke University and an MBA from the Stanford Graduate School of Business.
Michael B. Roaldi, Senior Vice President, Growth at UnitedHealthcare Community & State, UnitedHealthcare Community & State
Mike is the Senior Vice President, Growth, of Unitedhealthcare Community & State, and is responsible for business development and positioning, RFP development, performance & execution, DSNP product management, sales and retention, redeterminations, and overall growth operations. His team leads growth readiness across our health plans, driving performance improvements in our operating model prior to bid response as well as stand up local partnerships and programs to support our market growth strategy. Mike works closely with policymakers, member advocacy groups, and providers to position Unitedhealthcare appropriately in the marketplace. Mike’s prior roles include President of Government Programs for Optum Behavioral Health, and CEO of the UHC Ohio Health Plan. Mike is a member of the Colorado, Illinois, and Ohio bars. He also serves as a governing board member for the Tiny Lives Foundation, an organization which focuses on providing shelter and medical care to children affected by the HIV/AIDS epidemic in Mokhotlong, Lesotho. He also serves on The Kennedy Forum Industry Council for Youth Mental Health, a group of industry leaders and policymakers focused on improving access to mental health services. Mike received his undergraduate degree from the University of Notre Dame. He also received his law degree from the University of Notre Dame Law School.
Kristina Saffran, Co-Founder & CEO, Equip
Kristina Saffran is the cofounder and CEO of Equip, a virtual program that delivers modern eating disorder treatment through family-based care that promises lasting recovery at home. Prior to Equip, Kristina founded Project HEAL, a leading grassroots eating disorder non-profit dedicated to treatment access. Kristina is an Ashoka Fellow, a Forbes 30 under 30 social entrepreneur, and an honoree on both Inc’s Female Founders 100 and INSIDER’s 30 under 40 in Healthcare recognition lists. Kristina graduated from Harvard College with a bachelor's degree in psychology.
Josh Seidenfeld, Partner & Chair, Digital Health, Cooley
Josh Seidenfeld represents companies at all stages of their lifecycle, from startups to public companies with a focus on healthcare-related technology companies (both consumer and enterprise). He has represented issuers and underwriters in public offerings, has substantial experience representing both buyers and sellers in M&A and both issuers and investors in private company financings. Josh also regularly advises his clients on general corporate issues, securities matters and implications of proposed business transactions. Josh is a contributing editor of Cooley GO, an online resource with tools, forms, guidance and data for entrepreneurs and emerging companies. Over the past two years, Josh has advised his clients in 100+ private/public financings and 30 mergers, acquisitions, spinoffs or asset sale transactions. Prior to joining Cooley, Josh held several operating roles with early stage pre-revenue startups to multinational organizations. Most recently, he served as director of business development, strategic initiatives and corporate counsel for Practice Fusion, a venture-backed healthcare IT company. He holds a JD from Santa Clara University School of Law, an MBA from Santa Clara University Leavey School of Business and a BS, magna cum laude, from University of California, Riverside.
Munjal Shah, Co-Founder and CEO, Hippocratic AI
Munjal Shah is the co-founder and CEO of Hippocratic AI, a startup building the first safety-focused large language model (LLM) for healthcare. The company is on a mission to dramatically improve healthcare access, equity and outcomes through the use of generative AI. Munjal is a serial entrepreneur, startup advisor and investor. Prior to founding Hippocratic AI, Munjal served as co-founder and CEO of a healthcare startup leveraging AI to analyze health records to help seniors select the best Medicare Advantage plan. Munjal also served as co-founder and CEO of an AI computer vision and machine learning company that was acquired by Google and a marketplace management, research and analytics company that eventually sold to Alibaba. He holds a Master’s degree in Computer Science from Stanford University, with a focus on AI, and a Bachelor’s degree in Computer Science from US San Diego where his senior thesis explored the use of AI in the design of new therapeutics.
Lee Shapiro, Managing Partner, 7wire Ventures
Lee Shapiro is Managing Partner at 7wireVentures. He also served as CFO of Livongo Health until November 2020. He was President of Allscripts from 2002-2012. During his tenure as CFO, Livongo also had a successful secondary offering, raised $550M in convertible debt, and entered into an agreement to merge at the highest valuation, $18.5B, of any healthcare technology company, based on revenue multiples. The price of $159 per share was over six times the price of Livongo’s shares at the time of its IPO, just 12 months earlier. Lee serves on the boards of The American Heart Association, where he serves on the executive committee and is 2023-2025 Chair Elect; Click Therapeutics; and serves on the board and committees of various 7wireVentures portfolio companies. He is also a co-founder and board member of The World Innovation Network and the advisory committee of the University of Chicago Innovation Fund.
Sanjay K. Shetty, President, CenterWell, Humana, Inc.
Dr. Sanjay Shetty joined Humana in March 2023 as President, CenterWell. He is responsible for leading strategy, growth, and business operations across Pharmacy, Provider Services, and Home Solutions, in addition to scaling the company’s CenterWell capabilities to strengthen our payer-agnostic portfolio. Dr. Shetty is a member of the Humana Management Team and reports to President and Chief Executive Officer Bruce Broussard. Before joining Humana, Dr. Shetty was President of Steward Health Care Systems in Dallas, Texas, one of the nation’s largest and most successful accountable care organizations. In his nearly 13 years at Steward, he served in progressive roles overseeing day-to-day strategy and operations across all business lines, while leading the company’s value-based care approach. Prior to his time at Steward, Dr. Shetty worked at Bain & Company, supporting healthcare strategy, private equity, mergers and acquisitions, and clinical innovation. He also served on the faculty of Tufts University School of Medicine and Harvard Medical School. He is a board-certified diagnostic radiologist. Dr. Shetty is recognized throughout the healthcare industry as a thought leader, having published multiple scholarly articles, reviews, chapters, and books, in addition to frequently participating in speaking engagements, teaching, panels, and podcasts. He has served in multiple leadership roles for the American College of Radiology and the Massachusetts Radiological Society. Additionally, Dr. Shetty was most recently named to the Dallas 500 2023 by D CEO Magazine. Dr. Shetty earned an A.B. summa cum laude in Biochemical Sciences, an A.M. in Biology, and an M.D. from Harvard University. He also earned an MBA in finance from the Wharton School of the University of Pennsylvania, where he was named a Palmer Scholar.
Mandira Singh, Fractional Executive and Advisor
Mandira Singh brings more than a decade of experience to building and scaling leading companies in healthcare technology. Mandira currently serves as SVP and General Manager for the Acute & Payer business at PointClickCare, where she serves on the Executive Leadership Team and is focused on driving growth and delivering results for over a thousand hospitals and every national health plan in the U.S. Mandira joined PointClickCare via the acquisition of Collective Medical in December 2020, where she served as Chief Operating Officer. Prior to joining Collective, Mandira was Executive Director of Product, Platform at athenahealth, where she built athenahealth’s API-driven platform and created the industry’s leading developer experience. Previously, Mandira ran athenahealth’s More Disruption Please business unit including the athena Marketplace, which she grew from an initial business plan to a profitable business unit delivering more than 200 innovative apps to athena clients. Prior to joining athenahealth, Mandira was an investment professional at Essex Woodlands, a growth equity and venture capital firm focused on healthcare. Mandira started her career at J.P. Morgan, where she worked in the North America Healthcare Coverage Group and then the Private Equity Co-Investing group in New York. Mandira holds a BA in Economics from Vassar College and an MBA from the Stanford Graduate School of Business.
Michelle Snyder, Partner, McKesson Ventures
Michelle Snyder brings over 25 years’ healthcare industry experience in marketing, business development, strategic planning, public policy, and general management. Prior to joining McKesson Ventures, she was Chief Marketing Officer at Welltok as well as an early executive at Epocrates, where she worked for over a decade to build the company into one of the most recognized brands among clinicians. Her MV investments include CancerIQ, Galileo, Inbound Health, Reimagine Care, and RxVantage. Michelle has also served as an Executive-in-Residence at InterWest Partners, investing in digital health companies and advising portfolio companies. In addition, she has held consulting and policy positions at The Wilkerson Group, the Lewin Group and the Georgetown Center for Health Policy Studies. Michelle earned her M.B.A. at the Kellogg School of Management at Northwestern University and her B.A. from Carleton College. Though she’s been in the Bay Area for over 20 years, she still dons green and gold and wears her Cheesehead proudly on Sundays.
Ramita Tandon, Chief Clinical Trials Officer, Walgreens
As the Chief Clinical Trials Officer at Walgreens, Ramita Tandon is responsible for leading and driving growth for the Company’s new clinical trials business. In her role, Ramita works across the healthcare and life sciences industries to enable next-generation clinical trials so that breakthrough treatments reach patients faster. Her team is focused on unlocking value and improving access, awareness, and trust by efficiently matching diverse patient populations to sponsor-led trials, reducing trial operational complexities and patient burdens, as well as capitalizing on Walgreens' deep patient insights and leveraging real-world data from owned and partner assets. Ramita brings more than 25 years of leadership and operational experience across a portfolio of industry-leading businesses and services in real-world evidence and patient-centered health outcomes. Prior to joining Walgreens, she served as the Chief Operating Officer at Trio Health, and prior to that she was the Executive Vice President, Commercialization and Outcomes at ICON. As a transformational leader, Ramita is passionate in her belief that a best-in-class operating model employing insights and innovation can deliver gains in operations and forge stronger connections with all stakeholders, including biopharmaceutical companies, healthcare systems, and payers. Ramita has recently been named to Drug Store News’ Top Women in Health, Wellness & Beauty class of 2022 for Business Excellence, Fierce Healthcare’s 2022 Women of Influence, and listed in the 2018 PharmaVOICE 100. Ramita is an internationally recognized speaker and author whose focus is on how to bridge the gap between commercial and clinical development. She is a graduate of the University of Michigan and the Boston University School of Public Health.
Sara Vaezy, Executive Vice President, Chief Strategy and Digital Officer, Providence
Sara Vaezy is Executive Vice President and Chief Strategy and Digital Officer for Providence where she is responsible for system strategy and digital innovation for the integrated delivery network (IDN) which includes 52 hospitals and 1,085 clinics and serves over 5 million unique patients. Sara is the architect of the corporate strategy and digital Innovation model at Providence. The model has generated technology collaborations and the successful commercialization of three incubated technologies into new companies. She’s a thought leader for digital innovation, and her framework for building and maintaining deep organizational relationships with stakeholders across the industry has resulted in partnerships with over 150 health system digital and innovation teams, venture capital organizations, industry analysts and influencers, and digital health organizations. Sara is active in the broader healthcare industry serving as an NCQA Board Director, a Harvard Executive Education Faculty Member, a Health Evolution Forum Fellow, a Forbes Business Council Member, and a board observer for DexCare. She holds an MHA and an MPH in Health Policy from the University of Washington School of Public Health and BAs in Physics and Philosophy from the University of California, Berkeley.
Julie Yoo, General Partner, a16z
Julie Yoo is a General Partner at Andreessen Horowitz where she leads investments in healthcare technology, with a focus on companies that are modernizing how we access, pay for, and experience the healthcare system. Prior to joining a16z, Julie was the co-founder, Chief Product Officer, and Board Director at Kyruus, a venture-backed healthtech company recognized as a market leader in patient access. Julie led product management, engineering, and sales and marketing for the company, and helped scale the business to reach 20M patients and over 225,000 healthcare providers across the U.S. Julie was previously VP of Product at Generation Health, and was with the company from its inception through acquisition by CVS Health. Julie was also a Product Manager at Knome, the world's first whole genome sequencing service for private individuals. Julie’s tech career began as an early member of the software engineering team at Endeca Technologies, which was acquired by Oracle. Julie studied computer science and pre-medicine as an undergrad at MIT and obtained an MS in genomics from Harvard-MIT HST and an MBA from MIT Sloan. Julie is a Young Global Leader with the World Economic Forum and has been recognized through numerous awards and honors from Becker’s Hospital Review, Health Data Management, MedTech Boston, and Rock Health. Julie serves on a number of portfolio company boards, including AKASA, Bayesian Health, Firefly Health, Ribbon Health, Tomorrow Health, and Zus Health.
Kyle Zebley, Senior Vice President, Public Policy, American Telemedicine Association
Kyle Zebley is Senior Vice President of Public Policy at the American Telemedicine Association (ATA) and Executive Director of ATA Action. He is working with and on behalf of ATA and ATA Action members and like-minded organizations to eliminate barriers to the expansion of telehealth and ensure patients, providers, and payers can realize the benefits of virtual care. Previously, Kyle was the Chief of Staff in the Office of Global Affairs (OGA) at the U.S. Department of Health and Human Services (HHS). He collaborated with senior leadership from HHS, the White House, and other cabinet departments to develop, advise, and promote U.S. global health policy, including in such policy areas as drug pricing, global health security, medical devices, and non-communicable diseases. Prior to HHS, he worked in Congress as a Legislative Director, leading a legislative team in developing policy and drafting legislation, particularly on matters concerning the House Committee on the Budget, the House Committee on Education and the Workforce, and the House Committee on Ways and Means. Kyle started his career in Washington, D.C. as a Research Assistant at Public Opinion Strategies, where he worked on campaign strategies for clients running for U.S. President, U.S. Senate, the U.S. House of Representatives, state governor, and state legislatures. Kyle is a sought-after policy expert. He has contributed his time to organizations developing model health policies, such as the Federation of State Medical Boards Workgroup on Telemedicine, the Uniform Law Commission Uniform Telehealth Act, and the World Health Organization Independent High-level Commission on Noncommunicable Diseases. Kyle is frequently quoted in major media coverage on the topic of telehealth, including the Associated Press, Bloomberg, Inside Health Policy, Kaiser Health News, Modern Healthcare, NBC news affiliates, NPR, Roll Call, Time, USA Today, the Wall Street Journal, and Yahoo! Finance. In early 2022, Kyle was named by Politico as one of the “Four Washington players poised to shape digital health in 2022”.
Ashwini Zenooz, MD, Board Director, Commure
Ashwini Zenooz, MD is the board director of Commure. A board-certified radiologist, Dr. Zenooz has more than 20 years of clinical experience and has held leadership roles across the public and private sectors. At Salesforce, she was Chief Medical Officer and GM of Global Healthcare and Life Sciences. She served as Chief Medical Officer at the Department of Veterans Affairs overseeing the EHR modernization program. She has also held senior policy roles including serving as Brookings Legislative Health Policy Fellow with U.S. Senator Richard Blumenthal, and U.S. Senate Committee Staff. Dr. Zenooz received her MD in the Medical Honors Program at the University of Florida, completed her radiology residency at Henry Ford Health System, and an Abdominal Imaging fellowship at Massachusetts General Hospital.
